Chenxi Duan
About Chenxi Duan
Chenxi Duan is a Medical Science Manager specializing in immuno-oncology and virology at Bristol-Myers Squibb in New Jersey, United States.
Company
Chenxi Duan is currently working at Bristol-Myers Squibb in New Jersey, United States. Bristol-Myers Squibb is a leading global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines to patients with serious diseases. Chenxi Duan has been associated with this company in various roles, focusing primarily on immuno-oncology and virology.
Title
Chenxi Duan holds the title of Medical Science Manager at Bristol-Myers Squibb. Within this role, they specialize in immuno-oncology and virology, contributing to the development and management of medical science projects related to these fields. This position leverages their extensive knowledge and experience in the medical sciences.
Education and Expertise
Chenxi Duan studied at Université Joseph Fourier (Grenoble I), where they achieved a Masters in Biology from 2009 to 2014. This extensive five-year educational experience provided a solid foundation in biological sciences, equipping them with the expertise needed for their roles in medical science management. Their academic background supports their work in both immuno-oncology and virology.
Professional Background
Chenxi Duan's professional background includes a variety of roles in the medical and scientific fields. They started as a Managing Editor at MDPI in Basel, Switzerland, from 2015 to 2016. Following this, they joined Bristol-Myers Squibb, initially serving as an Associate Medical Science Manager from 2017 to 2018. In October 2018, they transitioned into the role of Medical Science Manager. Their experience spans both immuno-oncology and virology, reflecting a broad and deep understanding of these critical areas of medical science.
Immuno-Oncology and Virology Expertise
Chenxi Duan has extensive experience in both the immuno-oncology and virology fields. At Bristol-Myers Squibb, they have contributed significantly to projects and initiatives in these areas. Their dual specialization allows them to navigate complex challenges and advance medical science in ways that benefit patient outcomes. This expertise is underpinned by comprehensive educational and professional experiences, making them a key asset in their current role.